Clinical Trial Update: Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is assessing the use of methylphenidate for PTSD with associated neurocognitive complaints, sponsored by the VA Office of Research and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Posttraumatic Stress Disorder (PTSD) | Phase 4 | Status: RECRUITING